Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.96
-0.10-3.27%
Last update: Oct 2, 4:00 PM
$2.96
-0.10-3.27%
Larimar Therapeutics Inc (LRMR) Stock Price, Quote, News & History
LRMRNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Other companies in Larimar Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Larimar Therapeutics has a consensus price target of $15.38.
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $2.96 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Larimar Therapeutics.
Larimar Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Larimar Therapeutics.
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
